Meet PSI at UEG Week 2026!
Sponsors advancing gastroenterology programs are under increasing pressure to maintain enrollment predictability while managing protocol complexity, growing competition for sites, and rising operational demands across global studies.
PSI CRO, a global contract research organization founded in 1995 and operating across 58 countries, will attend UEG Week 2026 to discuss how GI sponsors can improve enrollment reliability and operational visibility in phase 2–3 studies.
PSI has supported 35% of all industry-sponsored ulcerative colitis trials and consistently enrolls 50%+ faster in GI indications compared to industry benchmarks. Attendees can discuss global GI trial execution strategies, feasibility planning, enrollment acceleration, and the operational application of AI-enabled trial intelligence.
Visit PSI at Booth #03
Meet with the PSI team to discuss GI enrollment strategies, operational planning for complex studies, and how PSI’s proprietary platforms including SYNETIC™ and VISIONAL™ support faster, more informed trial decisions.
Attending team members:
- Sylvia Demandewicz
Senior Director, Business Development - Alex Houlbrook
Senior Director, Business Development & Team Lead - Julia Smolina
Head of Project Supervision and Immunology - Olga Templing
Project Director
Related resources:
White paper: Placebo response in IBD trials- PSI CRO
Blog: Advances in IBD treatment considerations, GI trial design, and the impact of AI
Case Study: Managing enrollment and site performance in competitive upper GI trial programs
Webinar: Agentic AI in Clinical Trials — Swiss Biotech Day Panel
White Paper: The operational reality of agentic AI in phase 2-3 trials
